Olivier Harari

CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis

Julian D. Gillmore, Ed Gane, Jörg Täubel et al. · New England Journal of Medicine · 2021 · 1.5K citations · Full text

Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial

Hermine I. Brunner, Nicolino Ruperto, Zbigniew Żuber et al. · Annals of the Rheumatic Diseases · 2014 · 296 citations · Full text

Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease

Alejandro Recio‐Mayoral, Justin C. Mason, J C Kaski et al. · European Heart Journal · 2009 · 228 citations · Full text

Assessment of short-term symptomatic efficacy of tocilizumab in ankylosing spondylitis: results of randomised, placebo-controlled trials

Joachim Sieper, Benjamin Porter-Brown, Liz Thompson et al. · Annals of the Rheumatic Diseases · 2013 · 202 citations · Full text

First‐in‐human randomized study of bimekizumab, a humanized monoclonal antibody and selective dual inhibitor of IL‐17A and IL‐17F, in mild psoriasis

Sophie Glatt, Eric Helmer, Birgit Haier et al. · British Journal of Clinical Pharmacology · 2016 · 140 citations · Full text